We are live on ! Find out more
DVC

Deer VII & Co Portfolio holdings

AUM $317M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
AUM
$24.7M
AUM Growth
+$18.5M
Cap. Flow
+$27.9M
Cap. Flow %
112.72%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$27.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNA
1
DELISTED
Allena Pharmaceuticals
ALNA
$20.5M 82.81%
+2,263,365
New +$27.9M
VSTM icon
2
Verastem
VSTM
$547M
$3.65M 14.77%
99,197
TARA icon
3
Protara Therapeutics
TARA
$221M
$599K 2.42%
7,878

Similar funds

Deer VII & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Deer VII & Co held 3 positions worth $24.7M, up 298% from $6.22M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Deer VII & Co deployed $27.9M of net new capital in Q4 2017, opening 1 new position. Its largest new stake was Allena Pharmaceuticals: 2,263,365 shares worth $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Deer VII & Co's largest Q4 2017 buy was Allena Pharmaceuticals: 2,263,365 shares worth $20.5M.
  • Deer VII & Co's ten largest holdings make up 100% of its $24.7M portfolio in Q4 2017.
  • Deer VII & Co opened 1 new position and closed 0 in Q4 2017.
  • Deer VII & Co's portfolio value rose 298% quarter-over-quarter to $24.7M.

Based on Deer VII & Co's 13F filing for Q4 2017, filed 14 Feb 2018.